Neuroscience

Repurposing cancer drug to treat neuroinflammation

The repurposing of FDA-approved drugs for alternative diseases is a faster way of bringing new treatments into the clinic. Researchers at Karolinska Institutet in Sweden have repurposed a cancer drug for treatment of neuroinflammatory ...

Oncology & Cancer

Multicancer blood test, PET-CT combo feasible for cancer screen

(HealthDay)—Multicancer blood testing combined with positron emission tomography-computed tomography (PET-CT) imaging can detect cancers, according to a study published online April 28 in Science to coincide with the virtual ...

Surgery

Lung transplant with ex vivo lung perfusion feasible

(HealthDay)—Use of ex vivo lung perfusion (EVLP)-treated lungs increases the number of patients undergoing transplantation with comparable long-term outcomes, according to a study published online Oct. 9 in JAMA Surgery.

Diabetes

Metformin may increase risk of cognitive impairment

(HealthDay)—Metformin may increase the risk of cognitive impairment in patients with diabetes; however, calcium supplementation may attenuate this risk, according to research published online Sept. 5 in Diabetes Care.

Immunology

rhC1INH cuts attack frequency in hereditary angioedema

(HealthDay)—For patients with hereditary angioedema (HAE), weekly administration of recombinant C1INH (rhC1INH) is well tolerated and is associated with a reduction in attack frequency, according to a study published online ...

Other

US Supreme Court rejects blood monitoring patents

Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.

Vaccination

Collaboration will test a COVID-19 vaccine candidate

The University of Alabama at Birmingham is launching a collaboration with the biopharmaceutical company Altimmune, Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease.

page 1 from 2